Viewing data from:

DOXYLAMINE SUCCINATE

ANDA

DOXYLAMINE SUCCINATE | A040564 | LNK INTERNATIONAL INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.1231

per ea

Lowest NADAC/Unit

$0.1231

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
46122078815GNP NIGHTTIME SLEEP 25 MG TAB	$0.1231	EA	Generic	—	2026-06-17
70677112901FT SLEEP AID 25 MG TABLET	$0.1231	EA	Generic	—	2026-06-17
70000056701SLEEP AID 25 MG TABLET	$0.1231	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs9 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)DOXYLAMINE SUCCINATE USP

DMF 53991984

SIGMA ALDRICH IRELAND LTDDOXYLAMINE SUCCINATE USP

DMF 69081987

RL FINE CHEM PVT LTDDOXYLAMINE SUCCINATE

DMF 280272014

SHENZHEN ORIENTAL PHARMACEUTICAL CO LTDDOXYLAMINE SUCCINATE

DMF 318312017

HONOUR LAB LTDDOXYLAMINE SUCCINATE

DMF 374762022

MALLADI DRUGS AND PHARMACEUTICALS LTDDOXYLAMINE SUCCINATE

DMF 384872023

HY-GRO CHEMICALS PHARMTEK PRIVATE LTDDOXYLAMINE SUCCINATE

DMF 416952025

HOFFMANN LA ROCHE INCInactiveDOXYLAMINE SUCCINATE

DMF 36521979

BURDICK & JACKSON LABS,INCInactiveDOXYLAMINE SUCCINATE

DMF 36731979

POLIPHARM SPAInactiveDOXYLAMINE SUCCINATE USP

DMF 39221980

MALLINCKRODT PHARMS DIV MALLINCKRODT INCInactiveDOXYLAMINE SUCCINATE USP AS PRODUCED IN THE ST. LOUIS MO PLANT

DMF 40591981

CORDEN PHARMA BERGAMO SPAInactiveDOXYLAMINE SUCCINATE

DMF 47411982

YODOGAWA PHARMACEUTICAL CO LTDInactiveDOXYLAMINE SUCCINATE USP XXI

DMF 56891985

JT BAKER CHEMICAL COInactiveDOXYLAMINE SUCCINATE

DMF 70761987

ARCHIMICA SPAInactiveDOXYLAMINE SUCCINATE USP

DMF 72151987

UQUIFA ITALIA SPAInactiveDOXYLAMINE SUCCINATE USP

DMF 174172004

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 27, 2004

No patent or exclusivity listings for this strength.